Carlo Capirci - Publications

Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients.

Journal: Clinical and translational radiation oncology

Published: February 02, 2017

Value of (18)F-FDG PET for Predicting Response to Neoadjuvant Therapy in Rectal Cancer: Systematic Review and Meta-Analysis.

Journal: AJR. American journal of roentgenology

Published: May 23, 2015

Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience.

Journal: Tumori

Published: September 30, 2014

When and why to use FDG PET/CT in locally advanced rectal cancer: two scenarios.

Journal: Clinical nuclear medicine

Published: May 09, 2014

Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 28, 2014

Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patients.

Journal: International journal of cancer

Published: March 13, 2014

Biological target volume overlapping segmentation system method for avoiding false-positive PET findings in assessing response to neoadjuvant chemoradiation therapy in rectal cancer.

Journal: Clinical nuclear medicine

Published: December 05, 2013

Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients.

Journal: Anticancer research

Published: October 15, 2013

Proposal of a new 18F-FDG PET/CT predictor of response in rectal cancer treated by neoadjuvant chemoradiation therapy and comparison with PERCIST criteria.

Journal: Clinical nuclear medicine

Published: October 11, 2013

Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 23, 2012

Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: a phase 2 study.

Journal: Cancer

Published: June 05, 2012

A new methodological approach for PET implementation in radiotherapy treatment planning.

Journal: Nuclear medicine communications

Published: February 02, 2012